Home  |  Search:
Home >  
09/06/2011

SBIR/STTR Programs - The Gateway to Life Science Industry Non-Dilutive Funding

We are happy to accommodate requests for a re-broadcast of the following webinar:

FreeMind Group is pleased to invite you to our 10th webinar in a series of summer educational webinars focusing on the SBIR/STTR opportunities

 
Presenter:
Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group

Oftentimes, the SBIR/STTR programs are a necessary step that BioTech and Medical Device companies take in order to display their strengths and graduate to become prime candidates for large scale awards in the millions of dollars. Despite the fierce competition and seemingly limiting factors, if properly approached and neatly executed, this program may prove to be a substantial source of funding complementary to traditional sources. To meet these challenges, and to turn out a top quality application, it is more important than ever to understand the intricate requirements of the SBIR/STTR program, thus maximizing your chances for award.
In this webinar we will discuss:
  • SBIR/STTR regulations.
  • Leveraging your SBIR/STTR money to large scale funding opportunities. 
  • Industry & academia collaboration
  • Process for applying, requirements and limitations
  • How to maximize chances for success
  • Government funding as a strategic source of funding
 
The webinar is designed for experienced companies, as well as for first-time submitters, and researchers from the Academia who wish to increase their chances for award, as well as the total amount of funding awarded. 
Tuesday, September 6th at 1:00 PM-1:30 PM EDT
The webinar is FREE of charge. To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 221, or at Hannah@freemindconsultants.com


08/30/2011

Medical Device Non-Dilutive Funding: Trends & Opportunities

FreeMind Group is pleased to invite you to our 9th webinar in a series of summer educational webinars focusing on non-dilutive funding for medical devices
 
Presenter:
Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group

In a world in which both medical diagnostics and therapies are shifting towards minimally invasive technologies, it is not surprising that steadily increasing non-dilutive funding is available for innovative medical device companies. The scope of funding support covers the entire R&D cycle, from early stage exploratory and discovery work all the way to late stage clinical research and validation. In this webinar we will present the latest trends at the NIH and the new available funding opportunities with respect to medical devices.    
 In this webinar we will discuss:
  • Trends in medical device non-dilutive funding
  • Cross section analysis of different opportunities available
  • The NIBIB – The national institute of Biomedical Imaging and Bioengineering
  • Challenges
  • How to maximize chances for success
When:
Tuesday, August 30th at 1:00-1:30 PM EDT

The webinar is designed for experienced companies and researches from the academia, as well as for first-time submitters who wish to increase their chances for award, as well as the total amount of funding awarded. 
The webinar is FREE of charge.
To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 220, or at Hannah@freemindconsultants.com



08/23/2011

Details of a Detailed Budget

FreeMind Group is pleased to invite you to our 8th webinar in
a series of summer educational webinars focusing on how to accurately construct your budget while adhering to NIH guidelines
 
Presenter:
Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group

Putting together a budget for your grant submission is typically the last item to be addressed during the writing process. Reason being that the figures you are suggesting must reflect the work you are proposing to complete. That said, simply stating the cost per item is hardly enough, and a properly constructed justification is mandatory and weighs heavily on approval of your budget. When comprising the budget one must ensure an accurate completion of the document while adhering to NIH guidelines and stipulations. Items such as indirect costs, sub-contractors, sub-awards, salaries, and even travel expenses must be completed correctly. This becomes increasingly difficult when large and complex applications have several budgets feeding into one.
In this webinar we will discuss:
  •  Budget: Know the limits
  • Direct vs. Indirect
  • Facilities & Administration rate
  • Modular or detailed: which to use?
  • Allowable costs
  • Final tips
 When:
Tuesday, August 23rd at 1:00-1:30 PM EDT

The webinar is designed for experienced companies and researches from the academia, as well as for first-time submitters who wish to increase their chances for award, as well as the total amount of funding awarded. 
The webinar is FREE of charge. To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 220, or at Hannah@freemindconsultants.com

 

08/16/2011

DOD Funding Opportunities for Life Science Research

FreeMind Group is pleased to invite you to our 7th webinar in a series of summer educational webinars focusing on DOD non-dilutive funding
Presenter:
Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group

Navigating one's way around the numerous available funding opportunities within the Department of Defense (DoD) can be a daunting task, which sometimes leads to misperceptions about the submission process and the prospects for getting funded.  Since all of its agencies are highly mission-oriented, understanding the basic structure and focus of each agency within DoD is absolutely critical for a successful outcome.
How is DoD funding categorized? How is funding announced? How are funding decisions being made?  In the upcoming webinar we will give an overview of the major programs available through the DoD and discuss the key points in the process and in particular:
Department of Defense – DARPA, DTRA, TMT, CDMRP
  • CDMRP Research Programs
  • The Key to Understanding DARPA
  • Meeting the mission of DTRA
  • Immediate funding opportunities
  • Government funding as a strategic source of funding
When:
Tuesday, August 16th at 1:00-1:30 PM EDT

The webinar is designed for experienced companies and researches from the academia, as well as for first-time submitters who wish to increase their chances for award, as well as the total amount of funding awarded. 
The webinar is FREE of charge. To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 220, or at Hannah@freemindconsultants.com
08/09/2011

R Mechanism for Companies

FreeMind Group is pleased to invite you to FreeMind's 6th webinar in a series of summer educational webinars.
This Webinar will discuss the differences between R' mechanisms and the path to non-dilutive funding
Presenter:
Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group

Navigating your way around the numerous available funding mechanisms within the NIH can be challenging especially as the multiple NIH mechanisms are designed to address different stages of your R&D work. One can also breakdown the science into more focused applications targeting different institutes while utilizing alternative mechanisms. In fact, this part of any strategic assessment is the first stage and is of high importance in leading to a favorable outcome when targeting government funding.
Mechanisms differ by scope, eligibility, budget, basic objectives, grant sections and more.
We will give an overview on R mechanisms and present some available solicitation from each mechanism.
In this webinar we will discuss:
  • Different types of R' mechanism (RO1, R21, R33 etc.)
  • Target the Right Mechanism
  • R-Series NIH funding opportunities
  • Awards, regulations, applying, requirements and limitations
  • How to maximize chances for success
When:
Tuesday, August 9th at 1:00-1:30 PM EDT

The webinar is designed for experienced companies as well as for first-time submitters who wish to increase their chances for award, as well as the total amount of funding awarded. 
The webinar is FREE of charge. To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 220, or at Hannah@freemindconsultants.com
08/02/2011

Non-Dilutive Funding for Industry-Academia Partnerships

FreeMind Group is pleased to invite you to FreeMind's 5th webinar in a series of summer educational webinars.
This Webinar will discuss the importance of Industry-Academia Research Partnerships and paths to funding through non-dilutive sources
Presenter:
Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group

Industry-academia partnerships drive the life science market forward and the importance of sustaining and nurturing these relationships is high on the agenda of both industry and academic leaders. Over the past several years we are witnessing a changing direction at the NIH and other government granting agencies aimed at supporting these relationships.
This new direction, according to NIH Director Francis Collins, stems from the realization that the medical benefits of the current revolution in biology clearly cannot be achieved without vigorous and effective translation. This leads to a strong need for collaboration and partnering between the industrial sector and academia, which is also well reflected in the numerous grant programs supporting industry-academia collaborations and partnerships.
We will give an overview to the opportunities available for funding your industry-academia collaborations, using non-dilutive government funding.
In this webinar we will discuss:
  • Current Partnership Funding Opportunities
  •  Awards, regulations applying, requirements and limitations
  • Trends in Academic-Industry Collaborations
  • New Direction at the NIH
  • The challenges in putting together a complex and large scale application
  • How to maximize chances for success

When:
Tuesday, August 2nd at 1:00-1:30 PM EDT

The webinar is designed for experienced companies and researches from the academia, as well as for first-time submitters who wish to increase their chances for award, as well as the total amount of funding awarded. 
The webinar is FREE of charge. To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 220, or at Hannah@freemindconsultants.com
07/26/2011

CNS & Parkinson's Research Funding Opportunities

FreeMind Group & The Michael J. Fox Foundation are pleased to invite you to FreeMind's 4th webinar in a series of summer educational webinars.
This Webinar will be focusing on CNS &Parkinson's research non-dilutive funding
 
Presenters:
Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group
Tracey Mumford, Associate Director, Research Partnerships , The Michael J. Fox Foundation for Parkinson's Research
1.      CNS diseases and Parkinson's in particular are highly variable diseases and complex research objectives. As such, this field of research is targeted by several non-dilutive funding agencies, both private and federal. The Michael J. Fox Foundation (MJFF) is dedicated to delivering better treatments and, ultimately, a cure for Parkinson's disease. MJFF prioritizes research with the most promise for improving diagnosis and treatment.
MJFF - the largest private funder of Parkinson's research - awarded almost $50M in new grants in 2010. Over the past 10 years, the Foundation has funded over $250M in Parkinson's research. Other sources, like NIH, invest greatly in better understanding the causes and providing possible solutions to patients.
For over 12 years FreeMind Group (FMG) is the leading consulting firm on non-dilutive funding. Many of the projects for which FMG has assisted its clients focus on CNS in general and Parkinson's in particular. FMG's work supports research conducted within industry and academia and assists its clients to receive funding from Federal and private foundations alike. Recently, FMG and MJFF have joined forces in an attempt to further the financial support received by researchers in the field.

In this webinar we will discuss:
  • Upcoming program deadlines
  •  Awards, regulations applying, requirements and limitations
  • MJFF Priority Focus Areas
  • CNS & Parkinson's Research Funding Opportunities from different mechanisms 
  • The challenges in putting together a complex and large scale application
  • How to maximize chances for success
  • Industry & academia collaboration
When:
Tuesday, July 26th at 1:00-1:30 PM EDT

The webinar is designed for experienced companies and researches from the academia, as well as for first-time submitters who wish to increase their chances for award, as well as the total amount of funding awarded. 

The webinar is FREE of charge. To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 220, or at Hannah@freemindconsultants.com

 

07/19/2011

NIH/DOD Funding Opportunities for Life Science Companies

FreeMind Group is pleased to invite you to our 3rd webinar in a series of summer educational webinars focusing on NIH/DODnon-dilutive funding
 

Presenter:
Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group

We are witnessing a continuous movement by the NIH and DOD towards the life science industry, with a greater understanding as to the industry's needs, focus, and challenges. The scope of funding support given to industry R&D efforts from non-dilutive sources such as NIH and DOD covers the entire R&D cycle from early stage exploratory activities and all the way to late stage clinical research activities (Phase I, and II).
All non-dilutive sources are now expressing greater than ever interest in the R&D efforts of the industry, and more so in the unique set of skills and assets presented by collaborative academia-industry alliances. In the presentation we will discuss the latest trends at the NIH and DOD and the new available large scale and clinical stage funding opportunities.

In this webinar we will discuss:
  • The challenges in putting together a complex and large scale application
  • Short term/large scale funding opportunities
  • Process for applying, requirements and limitations
  • How to maximize chances for success
  • Industry & academia collaboration
  • Government funding as a strategic source of funding
When:
Tuesday, July 19th at 1:00-1:30 PM EDT

The webinar is designed for experienced companies, as well as for first-time submitters who wish to increase their chances for award, as well as the total amount of funding awarded. 
The webinar is FREE of charge. To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 221, or at Hannah@freemindconsultants.com
 

 
07/05/2011

SBIR/STTR Programs

SBIR/STTR Programs - The Gateway to
Life Science Industry Non-Dilutive Funding


FreeMind Group is pleased to invite you to a special Webinar to present the SBIR/STTR opportunities

 
Presenter:
Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group

Oftentimes, the SBIR/STTR programs are a necessary step that BioTech and Medical Device companies take in order to display their strengths and graduate to become prime candidates for large scale awards in the millions of dollars. Despite the fierce competition and seemingly limiting factors, if properly approached and neatly executed, this program may prove to be a substantial source of funding complementary to traditional sources. To meet these challenges, and to turn out a top quality application, it is more important than ever to understand the intricate requirements of the SBIR/STTR program, thus maximizing your chances for award.
In this webinar we will discuss:
  • SBIR/STTR regulations.
  • Leveraging your SBIR/STTR money to large scale funding opportunities. 
  • Industry & academia collaboration
  • Process for applying, requirements and limitations
  • How to maximize chances for success
  • Government funding as a strategic source of funding
 
The webinar is designed for experienced companies, as well as for first-time submitters, and researchers from the Academia who wish to increase their chances for award, as well as the total amount of funding awarded. 
Tuesday, July 5th at 1:00 PM-1:30 PM EDT
The webinar is FREE of charge. To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 220, or at Hannah@freemindconsultants.com



03/23/2011

Partnerships for Biodefense (R01)

FreeMind Group is pleased to invite you to
 a special webinar focusing on the latest announcement of the NIAID program, Partnerships for Biodefense (R01)
May 27, 2011 Deadline

 

Presenters: Ayal Ronen, MSc. Senior Director of Marketing and Sales,
FreeMind Group LLC

When:

Wednesday, March 23rd at 13:30-2:30 PM EST


Funding is available from various governments' sources to support R&D efforts for Biodefense, ranging from the very beginning of exploratory research and all the way to final stage clinical testing.
 
The purpose in this specific opportunity is to support preclinical development of lead candidate vaccines, therapeutics, adjuvants or diagnostics against NIAID Category A, B, or C priority agents. 
Up to $750,000 per year for a maximum period of 5 years.
In addition, up to a total of $300,000 for major equipment in the first year of the award.


Topics to be discussed:

§         A detailed discussion of "Partnerships for Biodefense (R01)"

§         Other Funding opportunities for Biodefense R&D

§         Application process, requirements and limitations

§         The differences between the requirements of different agencies and mechanisms

§         Industry–Academia collaboration

 

This event is free of charge; however an early registration is required.

 

Please contact Hannah Rosencweig at Hannah@freemindconsultants.com to register

 

10/07/2010

Non-Dilutive Funding For Medical Device Companies

Medical Device Non-Dilutive Funding:
Trends & Opportunities
 
FreeMind Group is pleased to invite you to a
special webinar focusing on medical device non-dilutive funding
Presenters: Guy Harchen, MSc. Grants Consultant
Department of Professional Services, FreeMind Group LLC

In a world in which both medical diagnostics and therapies are shifting towards minimally invasive technologies, it is not surprising that steadily increasing non-dilutive funding is available for innovative medical device companies. The scope of funding support covers the entire R&D cycle, from early stage exploratory and discovery work all the way to late stage clinical research and validation. In this webinar we will present the latest trends at the NIH and the new available funding opportunities.    
 In particular we will discuss :

  • Trends in medical device non-dilutive funding.
  • Cross section analysis of different opportunities available.
  • Industry & academia collaboration.
  • Process for applying, requirements and limitations.
  • How to maximize chances for success.
  • Government funding as a strategic source of funding
When:
Thursday, October 7th at 1:00-2:00 PM EDT

This Webinar is FREE of charge.

To register please contact:
Casey Levin at casey@freemindconsultants.com or at (617) 648-0340 ext. 216
 
Sponsors:

LifeScience Alley®  - www.lifesciencealleyconference.org
AdvaMed- www.advamed.org
06/09/2010

New Clinical Funding Opportunities Webinar

FreeMind Group is pleased to invite you to a special Webinar to present the clinical funding trends in the NIH

NIH Moves Towards The Life Science Industry:
New Clinical Funding Opportunities

Clinical funding at the NIH is undergoing a fundamental paradigm shift, with a clear movement towards the life science industry. This shift is exemplified both in the allocation of clinical funding by NIH Institutes, as well as the sweeping increase in solicitations offering funding for clinical trials. This is further demonstrated by several first-in-kind investigator-initiated solicitations by several institutes.

Presenter: Joel Knopf, Senior Consultant, FreeMind Group
Wednesday, June 9th at 12:30-1:30PM EDT

 The webinar is FREE of charge. To register, please contact Hannah Rosencweig at
(617) 648-0340, ext. 221, or at hannah@freemindconsultants.com

 

06/01/2010

The R&D Tax Credit - Final Regulations Webinar

The R&D Tax Credit - Final Regulations Webinar
 

Presenters:

Ram May-Ron, Managing Partner - FreeMind Group
Brian Cameron, Executive Vice President - Paradigm Partners

Tuesday, June 1st at 1:00-2:00 PM EDT
The webinar is FREE of charge.

To register, please contact Hanna Rosencweig at (617) 648-0340, ext. 221, or at Hannah@freemindconsultants.com

 

05/24/2010

Hot From the Press - R&D Tax Credit Final Regulations Published!! Webinar

 

FreeMind Group is pleased to invite you to two special webinars on:
Hot From the Press - R&D Tax Credit Final Regulations Published!!
On May 21st the IRS is expected to publish the final detailed regulations for the Therapeutic Discovery Project Tax Credit and Cash Grants Program. FreeMind and Paradigm experts will review the guidelines and present you with:
  • Criteria for qualifying projects 
  • Additional Criteria 
  • Detailed Definitions 
  • Exclusions 
  • Formats 
  • Timelines and deadlines 
  • All other information
Presenters:
Ram May-Ron, Managing Partner - FreeMind Group
Brian Cameron, Executive Vice President - Paradigm Partners
 
Monday, May 24th at 1:00-2:00 PM EDT
Monday, May 24th at 5:00-6:00 PM EDT
The webinar is FREE of charge.
To register, please contact Hanna Rosencweig at (617) 648-0340, ext. 221, or at Hannah@freemindconsultants.com
 

 

05/12/2010

10 common misperceptions on the R&D Tax Credit Program Webinar

 Due to the great number of attendees, and greater number of requests by companies that could not attend, FreeMind and Paradigm are happy to hold a second webinar focusing on the R&D Tax Credit Program.

10 common misperceptions on the R&D Tax Credit Program

Presenters:

Ram May-Ron, Managing Partner - FreeMind Group
Brian Cameron, Executive Vice President - Paradigm Partners

The webinar will take place on:

Monday, May 12th at 1:00PM EDT and is free of charge

To register or schedule time for a call please contact Casey Levin at casey@freemindconsultants.com (617) 6480340 ext. 216  

 

05/10/2010

10 common misperceptions on the R&D Tax Credit Program Webinar

 FreeMind Group is pleased to invite you to a special webinar about:

10 common misperceptions on the R&D Tax Credit Program

The Life Science R&D Tax Credit is indeed a remarkable opportunity that is expected to entail complex applications. To present our clients with the best combined set of skills FreeMind had partnered with Paradigm Partners the leading national R&D tax credit consulting firm.


Presenters:

Ram May-Ron, Managing Partner - FreeMind Group
Brian Cameron, Executive Vice President - Paradigm Partners

The webinar will take place on:

Monday, May 10th at 1:00PM EDT and is free of charge

To register or schedule time for a call please contact Casey Levin at casey@freemindconsultants.com (617) 6480340 ext. 216 

  

04/14/2010

Learn about the CAN initiative and about new funding levels for SBIR

Learn about the CAN initiative and about new funding levels for SBIR

FreeMind Group is pleased to invite you to a special webinar about:

CAN - The Cures Acceleration Network is a new clinical support initiative authorized as part of the Health Insurance Reform Bill, which will award grants to biotech companies, universities, and patient advocacy groups to support clinical research.

SBIR - Under the newly approved regulation SBIR funding has increased from $100K to $150K for an SBIR Phase I award; and from $750K to $1M for an SBIR Phase II award.

Presenter: Ram May-Ron, Vice President , FreeMind Group LLC

The webinar will take place on:

April 14th 2010 at 2:00 pm EDT

The webinar is FREE of charge. 
For further information please contact Casey Levin at (617) 648-0340 ext. 216 casey@freemindconsultants.com

10/27/2009

Immediate Large Scale Grants & Contracts for Life Science Companies

Immediate Large Scale Grants & Contracts for Life Science Companies

FreeMind Group is pleased to invite you to a
special webinar focusing on the latest announcement of the Diabetes, Cancer, Bio-defense, Psychiatry, and Health Care Infrastructure programs, as well as other available mechanisms for funding

Presenter: Joel Knopf, Senior Consultant
FreeMind Group LLC

In the past few weeks NIH has issued several large scale funding opportunities, grants and contracts in different fields. The deadline for these opportunities is between Nov 2009 and Jan 2010 and they will cover advanced research and development activities in the fields of Bio-Defense, Diabetes, Cancer, Psychiatry, and Health Care Infrastructure. In this webinar, a FreeMind expert will discuss the diverse opportunities, the differences between a standard grant application and a large scale one, the challenges these complex applications pose, and the ways to overcome them. Additional issues to be covered include:

  • The challenges in assembling a complex and large scale application
  • NIH in the wake of the 'stimulus avalanche'
  • Short term/Large scale funding opportunities
  • Process for applying, requirements and limitations
  • How to maximize chances for success
  • Government funding as a strategic source of funding

The webinar is designed for experienced companies as well as for first-time submitters who wish to increase their success rates and the total amount of funding awarded.

Tuesday, October 27th at 1:30-2:30 PM EDT

The webinar is FREE of charge. 
To register, please contact Hanna Rosencweig at (617) 648-0340, ext. 221, or at Hannah@freemindconsultants.com

 

07/28/2009

Government Funding for Infectious Diseases R&D Activities Webinar

Government Funding for Infectious Diseases R&D Activities 

FreeMind Group and BIO are pleased to invite you to a special webinar focusing on the latest announcement of the NIAID programs, as well as other available mechanisms for funding through DOD, MITI, BARDA and others

Presenters: Ram May-Ron, Vice President 
                      Merav Geva, PhD., Chief Analyst & Director of Professional Services
                      FreeMind Group LLC

Funding is available from different govt. sources to support R&D efforts for infectious diseases, ranging from the very beginning of exploratory research and all the way to final stage clinical testing. These mechanisms may often lead to future purchase opportunities and differ in focus and potential as well as in scope and in the appropriate presentation necessary for success. We will attempt to shed some light on available funding opportunities. In particular, we will touch upon:  

  • NIAID - Funding opportunities for BioDefense R&D
  • Other government agencies' funding opportunities for infectious diseases related research 
  • Application process, requirements and limitations, and the differences between the requirements of different agencies and mechanisms
  • How to maximize chances for success
  • Government funding as a strategic source of funding

The webinar is designed for experienced companies as well as for first-time submitters who wish to increase their success rates and the total amount of funding awarded. 

Tuesday, July 28th at 1:00-2:00 PM EDT

The webinar is FREE of charge.
To register, please contact Casey Levin at (617) 648-0340 ext. 216, or at casey@freemindconsultants.com 

07/14/2009

NIH Industry Focused RC3 Funding

NIH Industry Focused RC3 Funding  

Due to public demand 

FreeMind Group and BIO are pleased to invite you to a 2nd tutorial webinar focusing on the recently announced NIH RC3 Commercially Oriented Funding Opportunity

Presenter: Mr. Joel Knopf, MSc, MBA, Senior Consultant, FreeMind Group LLC 

Biomedical Research, Development and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Pilot Program (RC3) RFA-OD-09-008  

  • How to maximize your chances for success
  • Scope and objectives of the program
  • Funding
  • Eligibility and requirements

The webinar is designed for experienced companies as well as for first-time submitters who wish to increase their success rates and the total amount of funding awarded.  

Tuesday, July 14th at 3:00-4:00 PM EDT

The webinar is FREE of charge.
To register, please contact Hanna Rosencweig at (617) 648-0340, ext. 221, or at Hannah@freemindconsultants.com

07/01/2009

NIH Registration Webinar

FreeMind Group and BIO are pleased to invite you to a special
tutorial webinar focusing on the process of on-line registration to grants.gov. 

Presenter: Mr. Joel Knopf, MSc, MBA, Senior Consultant, FreeMind Group LLC

  • Why registration is needed
  • Why register in advance
  • Registration timeline
  • Registration process
  • Detailed registration walk-through

The webinar is designed for experienced companies as well as for first-time submitters who wish to increase their success rates and the total amount of funding awarded.

 To register, please contact Hanna Rosencweig at (617) 648-0340, ext. 221, or at Hannah@freemindconsultants.com